Labetalol Hydrochloride
- Product NDC
- 70934-574
- 11-digit product format
- 709340574
- Labeler code
- 70934
- Product ID
- 70934-574_abfc2290-6c54-cae9-e053-2995a90acb54
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA207863
- Marketing category
- ANDA
- Marketing start
- 2020-02-26
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-574-30 | 70934057430 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-574-30) | 2020-02-26 | 0000-00-00 | No | No | Current |
| 70934-574-60 | 70934057460 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-574-60) | 2020-03-19 | 0000-00-00 | No | No | Current |